<span id="6i2zk"></span>

    <span id="6i2zk"><output id="6i2zk"></output></span>

    Beijing Genesee Biotech, Inc

    — www.xiangyi123.com —

    A high-tech enterprise focusing on the development, production and sales of diagnostic products for tropical infectious diseases


    About Us

    Beijing Genesee Biotech, Inc. is a high-tech enterprise focusing on the development, production and sales of tropical infectious disease diagnostic products.

    Our company has two series of in vitro diagnostic reagents, Rapid Test and Elisa, which are exported to more than 100 countries and regions all over the world. The products have many advantages, such as simple and flexible operation, no site restriction, accurate results, etc., and have made outstanding contributions to global disease control, prevention, physical examination and screening.

    In September 2020, Beijing Genese Biotech, Inc. (BGB), together with CTK Biotech Inc (CTK), joined the SSI Diagnostica Group with offices and production in Denmark. Today BGB and CTK are wholly owned affiliates of SSI Diagnostica A/S Group. The Group CEO is based out of Hilleroed, Denmark. “Our R&D and technical personnel keep business cooperation all the year round and keep pace with international diagnostic technology. Our company's quality system meets the requirements of American cGMP, and the products developed and produced by our company have been successfully approved by WHO.

    Corporate Goals

    Innovative immune diagnosis advocates convenient detection

    Quality policy

    Quality oriented, continuous innovation, continuous training, regular review, high-quality products and first-class service

    Open, inclusive, innovative and realistic team

    Join a more meaningful cause and leave traces of life













    ? 2022

    Beijing Genesee Biotech, Inc

    Jing ICP Bei No. 20027480



    Enterprise mailbox